These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 23975839

  • 1. Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting.
    Yuan J, Watanabe M, Suliman M, Qureshi AR, Axelsson J, Bárány P, Heimbürger O, Stenvinkel P, Lindholm B.
    Nephrol Dial Transplant; 2015 Feb; 30(2):274-82. PubMed ID: 23975839
    [Abstract] [Full Text] [Related]

  • 2. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality.
    Honda H, Qureshi AR, Axelsson J, Heimburger O, Suliman ME, Barany P, Stenvinkel P, Lindholm B.
    Am J Clin Nutr; 2007 Sep; 86(3):633-8. PubMed ID: 17823427
    [Abstract] [Full Text] [Related]

  • 3. Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases.
    Chang YT, Wu HL, Guo HR, Cheng YY, Tseng CC, Wang MC, Lin CY, Sung JM.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3588-95. PubMed ID: 21444362
    [Abstract] [Full Text] [Related]

  • 4. Reliability of bioelectrical impedance analysis in the evaluation of the nutritional status of hemodialysis patients - a comparison with Mini Nutritional Assessment.
    Erdoğan E, Tutal E, Uyar ME, Bal Z, Demirci BG, Sayın B, Sezer S.
    Transplant Proc; 2013 Nov; 45(10):3485-8. PubMed ID: 24314938
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and Risk of Protein-Energy Wasting Assessed by Subjective Global Assessment in Older Adults With Advanced Chronic Kidney Disease: Results From the EQUAL Study.
    Windahl K, Faxén Irving G, Almquist T, Lidén MK, van de Luijtgaarden M, Chesnaye NC, Voskamp P, Stenvinkel P, Klinger M, Szymczak M, Torino C, Postorini M, Drechsler C, Caskey FJ, Wanner C, Dekker FW, Jager KJ, Evans M.
    J Ren Nutr; 2018 May; 28(3):165-174. PubMed ID: 29459026
    [Abstract] [Full Text] [Related]

  • 6. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimbürger O, Bárány P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P.
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [Abstract] [Full Text] [Related]

  • 7. Associations of adiponectin and leptin levels with protein-energy wasting, in end stage renal disease patients.
    Markaki A, Grammatikopoulou MG, Venihaki M, Kyriazis J, Perakis K, Stylianou K.
    Endocrinol Nutr; 2016 Nov; 63(9):449-457. PubMed ID: 27638461
    [Abstract] [Full Text] [Related]

  • 8. Protein-energy wasting, as well as overweight and obesity, is a long-term risk factor for mortality in chronic hemodialysis patients.
    Segall L, Moscalu M, Hogaş S, Mititiuc I, Nistor I, Veisa G, Covic A.
    Int Urol Nephrol; 2014 Mar; 46(3):615-21. PubMed ID: 24474221
    [Abstract] [Full Text] [Related]

  • 9. Subjective global assessment for the diagnosis of protein-energy wasting in nondialysis-dependent chronic kidney disease patients.
    Cuppari L, Meireles MS, Ramos CI, Kamimura MA.
    J Ren Nutr; 2014 Nov; 24(6):385-9. PubMed ID: 25106727
    [Abstract] [Full Text] [Related]

  • 10. Leptin and ghrelin in chronic kidney disease: their associations with protein-energy wasting.
    Canpolat N, Sever L, Agbas A, Tasdemir M, Oruc C, Ekmekci OB, Caliskan S.
    Pediatr Nephrol; 2018 Nov; 33(11):2113-2122. PubMed ID: 29980850
    [Abstract] [Full Text] [Related]

  • 11. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients.
    Carrero JJ, Nakashima A, Qureshi AR, Lindholm B, Heimbürger O, Bárány P, Stenvinkel P.
    Kidney Int; 2011 Apr; 79(7):749-56. PubMed ID: 21178976
    [Abstract] [Full Text] [Related]

  • 12. Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease.
    Mukai H, Ming P, Lindholm B, Heimbürger O, Barany P, Anderstam B, Stenvinkel P, Qureshi AR.
    PLoS One; 2018 Apr; 13(4):e0195585. PubMed ID: 29702682
    [Abstract] [Full Text] [Related]

  • 13. Criteria for classification of protein-energy wasting in dialysis patients: impact on prevalence.
    Gracia-Iguacel C, González-Parra E, Mahillo I, Ortiz A.
    Br J Nutr; 2019 Jun; 121(11):1271-1278. PubMed ID: 31084673
    [Abstract] [Full Text] [Related]

  • 14. Predictors of protein-energy wasting in haemodialysis patients: a cross-sectional study.
    Ruperto M, Sánchez-Muniz FJ, Barril G.
    J Hum Nutr Diet; 2016 Feb; 29(1):38-47. PubMed ID: 25257462
    [Abstract] [Full Text] [Related]

  • 15. Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease.
    Kovesdy CP, George SM, Anderson JE, Kalantar-Zadeh K.
    Am J Clin Nutr; 2009 Aug; 90(2):407-14. PubMed ID: 19535427
    [Abstract] [Full Text] [Related]

  • 16. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance.
    Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bárány P, Lönnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P.
    Kidney Int; 2006 Feb; 69(3):596-604. PubMed ID: 16395259
    [Abstract] [Full Text] [Related]

  • 17. Protein-energy wasting syndrome in advanced chronic kidney disease: prevalence and specific clinical characteristics.
    Pérez-Torres A, González Garcia ME, San José-Valiente B, Bajo Rubio MA, Celadilla Diez O, López-Sobaler AM, Selgas R.
    Nefrologia (Engl Ed); 2018 Feb; 38(2):141-151. PubMed ID: 28755901
    [Abstract] [Full Text] [Related]

  • 18. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N, Leurs P, Qureshi AR, Bruchfeld A, Anderstam B, Heimburger O, Bárány P, Stenvinkel P, Lindholm B.
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [Abstract] [Full Text] [Related]

  • 19. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease.
    Malatino LS, Mallamaci F, Benedetto FA, Bellanuova I, Cataliotti A, Tripepi G, Zoccali C.
    Am J Kidney Dis; 2000 Nov; 36(5):945-52. PubMed ID: 11054350
    [Abstract] [Full Text] [Related]

  • 20. Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patients.
    Honda H, Ueda M, Kojima S, Mashiba S, Suzuki H, Hosaka N, Hirai Y, Nakamura M, Nagai H, Kato N, Mukai M, Watanabe M, Takahashi K, Shishido K, Akizawa T.
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1021-8. PubMed ID: 20395357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.